Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib

Overview of attention for article published in Frontiers in oncology, January 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 42 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 13 publications that cite this research output.

13

The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.

Yttrium-90 transarterial radioembolization and capecitabine in hepatocellular carcinoma with portal vein involvement

Article in Medicine (September 2023)

Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review

Article in Frontiers in Immunology (April 2023)

Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center

Article in Journal of Gastrointestinal Oncology (August 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.